The looming deadline for drugmakers to comply with the Most Favored Nation drug pricing policy raises concerns over potential disruptions to Medicare Part D, highlighting regulatory and market risks for U.S. drug pricing and federal entitlement programs.
Humana's stock sees an 18% decline over 12 months despite 7% revenue and 21% net income growth. Regulatory and operational challenges may impact future earnings.
Kansas City Life Insurance Co. agrees to a $40 million settlement over allegations of excessive life insurance costs, benefitting policyholders nationwide with plans active since 2002. Legal and regulatory insights included.
As Medicare open enrollment begins, scammers increase efforts to steal seniors' personal and Medicare information through fraudulent calls. Learn how to detect and prevent Medicare-related fraud effectively.
UnitedHealth expects 78% of members in Medicare Advantage plans rated four stars or higher for 2026, supporting government reimbursements and financial outlook amid cost pressures.
Elevance Health and leading insurers recalibrate Medicare Advantage plans and Part D coverage amid rising costs and regulatory shifts, focusing on risk management and compliance.
Virginia smokers with Obamacare coverage benefit from reduced health insurance premiums as FDA delays in tobacco product approvals persist. Key insights into regulatory impact on insurance costs.
Demotech uncovers AI-driven claim instigation tactics fueling litigation and insolvency risks in the U.S. transportation insurance sector, prompting industry-focused legislative discussions and strategic defense initiatives.
The Maryland Supreme Court ruled that anti-assignment clauses in insurance policies do not prohibit assignment of post-loss claims, impacting claims handling and policy interpretation.
The 2026 ACA marketplace anticipates the largest premium increases in five years amid market instability, tax credit expirations, and rising healthcare costs.
